Patents by Inventor Mauricio Farez

Mauricio Farez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Melatonin in autoimmune disease
    Patent number: 10555919
    Abstract: Methods for treating, or reducing risk of developing, seasonal worsening of multiple sclerosis (MS) in a subject who has MS, comprising administering a melatonin agonist to a subject.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: February 11, 2020
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Mauricio Farez, Francisco J. Quintana, Jorge Correale
  • MELATONIN IN AUTOIMMUNE DISEASE
    Publication number: 20170333371
    Abstract: Methods for treating, or reducing risk of developing, seasonal worsening of multiple sclerosis (MS) in a subject who has MS, comprising administering a melatonin agonist to a subject.
    Type: Application
    Filed: November 12, 2015
    Publication date: November 23, 2017
    Applicant: The Brigham and Women's Hospital, Inc.
    Inventors: Mauricio Farez, Francisco J. Quintana, Jorge Correale
  • Methods of Diagnosing and Treating Multiple Sclerosis
    Publication number: 20140343095
    Abstract: Methods of using a 15-oxysterol, e.g., 15-ketocholestene (15-KE), 15-ketocholestane (15-KA), and/or 15-hydroxy-cholestene (15-HC), as a biomarker to monitor disease progression in multiple sclerosis (MS), and methods of treating secondary progressive MS (SPMS) using inhibitors of poly(ADP ribose) polymerase-1 (PARD-1).
    Type: Application
    Filed: August 1, 2014
    Publication date: November 20, 2014
    Inventors: Howard Weiner, Francisco J. Quintana, Mauricio Farez
  • Methods of Diagnosing and Treating Multiple Sclerosis
    Publication number: 20120077770
    Abstract: Methods of using a 15-oxysterol, e.g., 15-ketocholestene (15-KE), 15-ketocholestane (15-KA), and/or 15-hydroxy-cholestene (15-HC), as a biomarker to monitor disease progression in multiple sclerosis (MS), and methods of treating secondary progressive MS (SPMS) using inhibitors of poly(ADP ribose) polymerase-1 (PARP-1).
    Type: Application
    Filed: January 21, 2010
    Publication date: March 29, 2012
    Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Howard Weiner, Francisco J. Quintana, Mauricio Farez